Reference
Reference TypeLiterature
TitlePromiscuity of Peptides Presented in HLA-DP Molecules from Different Immunogenicity Groups Is Associated With T-Cell Cross-Reactivity.
AuthorsAicha Laghmouchi; Michel G D Kester; Conny Hoogstraten; Lois Hageman; Wendy de Klerk; Wesley Huisman; Eva A S Koster; Arnoud H de Ru; Peter van Balen; Sebastian Klobuch; Peter A van Veelen; J H Frederik Falkenburg; Inge Jedema
AffiliationsDepartment of Hematology, Leiden University Medical Center, Leiden, Netherlands; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.
JournalFront Immunol
Year2022
AbstractIn the context of HLA-DP-mismatched allogeneic stem cell transplantation, mismatched HLA-DP alleles can provoke profound allo-HLA-DP-specific immune responses from the donor T-cell repertoire leading to graft-versus-leukemia effect and/or graft-versus-host disease in the patient. The magnitude of allo-HLA-DP-specific immune responses has been shown to depend on the specific HLA-DP disparity between donor and patient and the immunogenicity of the mismatched HLA-DP allele(s). HLA-DP peptidome clustering (DPC) was developed to classify the HLA-DP molecules based on similarities and differences in their peptide-binding motifs. To investigate a possible categorization of HLA-DP molecules based on overlap of presented peptides, we identified and compared the peptidomes of the thirteen most frequently expressed HLA-DP molecules. Our categorization based on shared peptides was in line with the DPC classification. We found that the HLA-DP molecules within the previously defined groups DPC-1 or DPC-3 shared the largest numbers of presented peptides. However, the HLA-DP molecules in DPC-2 segregated into two subgroups based on the overlap in presented peptides. Besides overlap in presented peptides within the DPC groups, a substantial number of peptides was also found to be shared between HLA-DP molecules from different DPC groups, especially for groups DPC-1 and -2. The functional relevance of these findings was illustrated by demonstration of cross-reactivity of allo-HLA-DP-reactive T-cell clones not only against HLA-DP molecules within one DPC group, but also across different DPC groups. The promiscuity of peptides presented in various HLA-DP molecules and the cross-reactivity against different HLA-DP molecules demonstrate that these molecules cannot be strictly categorized in immunogenicity groups.
External LinkPXD030591
Curation Last Updated2024-09-17 03:00:39
Epitope
Epitope ID760606
Chemical TypeLinear peptide
Linear SequenceGSTMLTSQYVRLTPD
Source Molecule NameVesicular integral-membrane protein VIP36
Source OrganismHomo sapiens (human)
Starting Position79
Ending Position93
Epitope Reference Details
Epitope Structure DefinesExact Epitope
Epitope NameEluted Peptide 4970
Location of Data in ReferenceAuthor Provided
In Vivo Processing
Host OrganismHomo sapiens (human)
Host Details
SexF
Age53 years
In Vivo Process
In Vivo Process TypeNo immunization
Disease Statehealthy
Antigen Processing Comments
Antigen Processing CommentsHLA class I and II-negative human immortalized myelogenous leukemia (K562) cell lines were transduced with individual HLA-DP alleles and utilized for ligand elution.
MHC Ligand Assay
Qualitative MeasurementPositive
Method/Techniquecellular MHC/mass spectrometry
Measurement ofligand presentation
Antigen Presenting Cells
Cell Tissue TypeBone Marrow
Cell TypeK562-Myeloid cellhttp://purl.obolibrary.org/obo/CLO_0007050
Cell Culture ConditionsCell Line / Clone
MHC Allele
MHC Allele NameHLA-DPA1*01:03/DPB1*04:02
MHC Evidence CodeSingle allele present
MHC Ligand
Epitope RelationEpitope
Chemical TypeLinear peptide
Linear SequenceGSTMLTSQYVRLTPD
Source Molecule NameVesicular integral-membrane protein VIP36
Source OrganismHomo sapiens (human)
Starting Position79
Ending Position93
Assay Reference Details
Location of Assay Data in ReferenceAuthor Provided